US Bancorp’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3
| Closed | -$1 | – | 4421 |
|
|
2024
Q4 | $1 | Hold |
3
| – | – | ﹤0.01% | 4154 |
|
|
2024
Q3 | $6 | Hold |
3
| – | – | ﹤0.01% | 4070 |
|
|
2024
Q2 | $16 | Hold |
3
| – | – | ﹤0.01% | 3957 |
|
|
2024
Q1 | $9 | Hold |
3
| – | – | ﹤0.01% | 3950 |
|
|
2023
Q4 | $19 | Sell |
3
-1
| -25% | -$8 | ﹤0.01% | 3943 |
|
|
2023
Q3 | $94 | Hold |
4
| – | – | ﹤0.01% | 3937 |
|
|
2023
Q2 | $31 | Hold |
4
| – | – | ﹤0.01% | 3963 |
|
|
2023
Q1 | $196 | Hold |
4
| – | – | ﹤0.01% | 4024 |
|
|
2022
Q4 | $606 | Hold |
4
| – | – | ﹤0.01% | 3981 |
|
|
2022
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 3884 |
|
|
2022
Q2 | $3K | Hold |
4
| – | – | ﹤0.01% | 3774 |
|
|
2022
Q1 | $11K | Hold |
4
| – | – | ﹤0.01% | 3356 |
|
|
2021
Q4 | $10K | Hold |
4
| – | – | ﹤0.01% | 3440 |
|
|
2021
Q3 | $17K | Hold |
4
| – | – | ﹤0.01% | 3222 |
|
|
2021
Q2 | $22K | Hold |
4
| – | – | ﹤0.01% | 3103 |
|
|
2021
Q1 | $30K | Buy |
4
+1
| +33% | +$10.6K | ﹤0.01% | 2846 |
|
|
2020
Q4 | $22K | Hold |
3
| – | – | ﹤0.01% | 2884 |
|
|
2020
Q3 | $23K | Hold |
3
| – | – | ﹤0.01% | 2767 |
|
|
2020
Q2 | $21K | Hold |
3
| – | – | ﹤0.01% | 2804 |
|
|
2020
Q1 | $11K | Hold |
3
| – | – | ﹤0.01% | 3005 |
|
|
2019
Q4 | $20K | Sell |
3
-1
| -25% | -$9.45K | ﹤0.01% | 2894 |
|
|
2019
Q3 | $46K | Buy |
4
+1
| +33% | +$8.03K | ﹤0.01% | 2514 |
|
|
2019
Q2 | $28K | Hold |
3
| – | – | ﹤0.01% | 2769 |
|
|
2019
Q1 | $44K | Hold |
3
| – | – | ﹤0.01% | 2545 |
|
|
2018
Q4 | $51K | Hold |
3
| – | – | ﹤0.01% | 2442 |
|
|
2018
Q3 | $125K | Hold |
3
| – | – | ﹤0.01% | 2110 |
|
|
2018
Q2 | $130K | Hold |
3
| – | – | ﹤0.01% | 2086 |
|
|
2018
Q1 | $109K | Hold |
3
| – | – | ﹤0.01% | 2191 |
|
|
2017
Q4 | $69K | Hold |
3
| – | – | ﹤0.01% | 2444 |
|
|
2017
Q3 | $71K | Buy |
+3
| New | +$55.7K | ﹤0.01% | 2407 |
|
US Bancorp's TTOO Position: Q1 2025 in Review
US Bancorp sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 3 shares — an estimated $1 sold.
US Bancorp first reported a position in TTOO in Q3 2017 and held it in 30 quarters. The position peaked at $130K in Q2 2018. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- US Bancorp reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- US Bancorp sold 3 T2 Biosystems, Inc shares in Q1 2025, an estimated $1.
- US Bancorp first reported a position in T2 Biosystems, Inc in Q3 2017 and held it in 30 quarters.
- US Bancorp's T2 Biosystems, Inc position peaked at $130K in Q2 2018.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.